Jessica W Hui1, Jason Ong2, James J Herdegen2, Hajwa Kim3, Christopher D Codispoti4, Vahid Kalantari4, Mary C Tobin4, Robert P Schleimer5, Pete S Batra6, Phillip S LoSavio6, Mahboobeh Mahdavinia7. 1. Department of Internal Medicine and Pediatrics, Rush University Medical Center, Chicago, Illinois. 2. Sleep Disorders Service and Research Center, Rush University Medical Center, Chicago, Illinois. 3. Center for Clinical and Translational Science, University of Illinois at Chicago, Chicago, Illinois. 4. Department of Immunology and Microbiology, Allergy/Immunology Section, Rush University Medical Center, Chicago, Illinois. 5. Division of Allergy-Immunology, Departments of Medicine, Otolaryngology, and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 6. Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois. 7. Department of Immunology and Microbiology, Allergy/Immunology Section, Rush University Medical Center, Chicago, Illinois. Electronic address: Mahboobeh_mahdavinia@rush.edu.
Abstract
BACKGROUND: It is widely known that patients with chronic rhinosinusitis (CRS) commonly experience sleep disruption. Many of these patients have the associated diagnosis of obstructive sleep apnea (OSA). However, little is known about the risk factors for developing OSA in the CRS population. OBJECTIVE: To identify the risk factors for OSA in CRS to determine who should be screened for OSA among patients with CRS. METHODS: We evaluated a large cohort of patients with confirmed diagnostic criteria for CRS. Patient medical records were reviewed to identify those with OSA confirmed by overnight polysomnography. Records were further reviewed for demographic information (age, sex, race, and ethnicity), body mass index, and medical history, including the presence of nasal polyps, asthma, aspirin-exacerbated respiratory disease, allergic rhinitis, and eczema. The number of endoscopic sinus operations, duration of CRS, presence of subjective smell loss, and computed tomography Lund-Mackay score were also ascertained. RESULTS: A total of 916 patients with CRS were included in the study. Implementation of a multivariable regression model for identifying adjusted risk factors revealed that African American patients had a significantly higher risk for OSA than white patients, with an adjusted odds ratio of 1.98 (95% confidence interval, 1.19-3.29). Furthermore, patients with CRS without nasal polyps were at higher risk for OSA, with an odds ratio of 1.63 (95% confidence interval, 1.02-2.61) compared with patients with CRS with nasal polyps. CONCLUSION: African American patients with CRS were at higher risk for OSA compared with white patients, and this patient group needs to be screened for OSA.
BACKGROUND: It is widely known that patients with chronic rhinosinusitis (CRS) commonly experience sleep disruption. Many of these patients have the associated diagnosis of obstructive sleep apnea (OSA). However, little is known about the risk factors for developing OSA in the CRS population. OBJECTIVE: To identify the risk factors for OSA in CRS to determine who should be screened for OSA among patients with CRS. METHODS: We evaluated a large cohort of patients with confirmed diagnostic criteria for CRS. Patient medical records were reviewed to identify those with OSA confirmed by overnight polysomnography. Records were further reviewed for demographic information (age, sex, race, and ethnicity), body mass index, and medical history, including the presence of nasal polyps, asthma, aspirin-exacerbated respiratory disease, allergic rhinitis, and eczema. The number of endoscopic sinus operations, duration of CRS, presence of subjective smell loss, and computed tomography Lund-Mackay score were also ascertained. RESULTS: A total of 916 patients with CRS were included in the study. Implementation of a multivariable regression model for identifying adjusted risk factors revealed that African American patients had a significantly higher risk for OSA than white patients, with an adjusted odds ratio of 1.98 (95% confidence interval, 1.19-3.29). Furthermore, patients with CRS without nasal polyps were at higher risk for OSA, with an odds ratio of 1.63 (95% confidence interval, 1.02-2.61) compared with patients with CRS with nasal polyps. CONCLUSION: African American patients with CRS were at higher risk for OSA compared with white patients, and this patient group needs to be screened for OSA.
Authors: Lyle J Palmer; Sarah G Buxbaum; Emma K Larkin; Sanjay R Patel; Robert C Elston; Peter V Tishler; Susan Redline Journal: Am J Respir Crit Care Med Date: 2004-04-07 Impact factor: 21.405
Authors: C Bachert; N Van Bruaene; E Toskala; N Zhang; H Olze; G Scadding; C M Van Drunen; J Mullol; L Cardell; P Gevaert; T Van Zele; S Claeys; C Halldén; K Kostamo; U Foerster; M Kowalski; K Bieniek; A Olszewska-Ziaber; E Nizankowska-Mogilnicka; A Szczeklik; M Swierczynska; M Arcimowicz; V Lund; W Fokkens; T Zuberbier; C Akdis; G Canonica; P Van Cauwenberge; P Burney; J Bousquet Journal: Allergy Date: 2009-04 Impact factor: 13.146
Authors: Jeremiah A Alt; Adam S DeConde; Jess C Mace; Toby O Steele; Richard R Orlandi; Timothy L Smith Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-10 Impact factor: 8.961
Authors: Sanjay R Patel; Robert Goodloe; Gourab De; Matthew Kowgier; Jia Weng; Sarah G Buxbaum; Brian Cade; Tibor Fulop; Sina A Gharib; Daniel J Gottlieb; David Hillman; Emma K Larkin; Diane S Lauderdale; Li Li; Sutapa Mukherjee; Lyle Palmer; Phyllis Zee; Xiaofeng Zhu; Susan Redline Journal: PLoS One Date: 2012-11-14 Impact factor: 3.240
Authors: Mitesh P Mehta; Kevin Hur; Caroline P E Price; Stephanie Shintani-Smith; Kevin C Welch; David B Conley; Robert C Kern; Bruce K Tan Journal: Laryngoscope Investig Otolaryngol Date: 2021-09-18
Authors: Astrid P Heikema; Deborah Horst-Kreft; Stefan A Boers; Rick Jansen; Saskia D Hiltemann; Willem de Koning; Robert Kraaij; Maria A J de Ridder; Chantal B van Houten; Louis J Bont; Andrew P Stubbs; John P Hays Journal: Genes (Basel) Date: 2020-09-21 Impact factor: 4.096